[Trophoblastic pregnancy persistant disease with a menopausal woman: ultrasonography-Doppler benefits].
We present the case of a 53-year-old menopaused woman who developed an invasive persistent trophoblastic uterine disease with several lung metastasis. Patient case was listed in a highly risked group in the WHO classification. As the patient refused primary hysterectomy she received polychemotherapy alone. Monitoring of the treatment and vascularity evolution of the tumor was followed through pelvic endovaginal ultrasound using 3D and contrast enhancement as well as HCG decrease in the context of uterus conservation that was wished by the patient.
Benabu-Saada
L
L
Pôle de gynécologie-obstétrique, hôpital Bretonneau, centre hospitalier universitaire de Tours, 2, boulevard Tonnellé, 37000 Tours, France. lisasaada@free.fr
Roussel
E
E
Body
G
G
Marret
H
H
D000971:Antineoplastic Combined Chemotherapy Protocols; D006063:Chorionic Gonadotropin / Q000097:blood; D005260:Female; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy / Q000556:secondary; D008875:Middle Aged; D009362:Neoplasm Metastasis; D016896:Treatment Outcome; D014328:Trophoblastic Neoplasms / Q000000981:diagnostic imaging / Q000188:drug therapy / Q000473:pathology*; D018608:Ultrasonography, Doppler / Q000379:methods*; D014594:Uterine Neoplasms / Q000000981:diagnostic imaging / Q000188:drug therapy / Q000473:pathology*
D006063:Chorionic Gonadotropin